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The aim of genetic tests performed by Genetic Counsel-
ing at Centre of Oncology was to screen for carriers of
germline mutations in BRCA1 and 2 genes who are at
high risk of developing breast or/and ovarian cancer.
Among the patients qualified to genetic tests there are
the patients who do not meet the Amsterdam criteria of
HBOC syndrome.
In Genetic Counseling at Centre of Oncology we find
germline mutations in BRCA1 and 2 genes in about 5%
of patients. Beginning in January 2003 until now we
found mutations in BRCA genes in 247 families. Not all
families belong to the group of high risk of developing
breast or ovarian cancer. Among them there were 23
families which did not meet pedigree and clinical
criteria.
Analysis of tumors which were developed by the
members of families carrying germline mutations in
BRCA1/2 genes revealed mainly breast (415) and ovar-
ian (170) cancers. There were also tumors which were
not typical for this mutation. The most frequent not
typical tumors in the families with germline BRCA1/2
mutations were: lung cancer (38), intestinal tract tumors
(26) – including stomach cancer, liver cancer (20), pan-
creas cancer (15) and also hematopoietic tumors –
among them leukemias (17), prostate cancer (14) and
other.
These findings justify performing genetic tests for
germline mutations in BRCA1/2 genes not only for the
patients who meet pedigree and clinical criteria typical
for HBOC syndrome.
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